Seminar – Patrick Lao, PhD – Topic: A Multiple Biomarker Approach to Alzheimer’s Disease for Underrepresented and Underserved Groups

Dr. Lao’s research focuses on a multiple biomarker approach to Alzheimer’s disease (i.e., amyloid-β, hyperphosphorylated tau, cerebrovascular disease, and neurodegeneration), informed by contextual factors (i.e., genetic, biological, social, environmental) for underrepresented and underserved groups, will provide the most reliable understanding of the complex disease course.

Thoughts of gratitude: The Dewey family is a catalyst of support for the Waisman Center

Individuals with Down syndrome are at higher risk of developing Alzheimer’s disease, and it typically presents it at an earlier age than the general population. It is estimated that 90% of people with Down syndrome will have developed Alzheimer’s by age 65.

Barbara Bendlin, PhD – Slide of the Week

Insulin resistance (IR) has been related to reduced cerebral glucose metabolism in regions identified as hypometabolic in Alzheimer’s clinical syndrome. Insulin secretion (IS) has been less studied than IR despite findings that decreased IS is an early indicator of future type 2 diabetes and a potential predictor of Alzheimer’s clinical syndrome.

Studying the connection between Alzheimer’s and Down syndrome for Down syndrome awareness month

By Emily Leclerc, Waisman Science Writer The month of October is Down Syndrome Awareness Month and is dedicated to not only raising awareness about Down syndrome but also to celebrating the abilities and accomplishments of …